Pharma-Bio Serv Announces Results for the Year Ended October 31, 2018

Author's Avatar
Apr 12, 2019
Article's Main Image

DORADO, PUERTO RICO / ACCESSWIRE / January 29, 2019/ Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced net revenues from continuing operations for the year ended October 2018 were $17.8 million, an increase of $4.5 million, or 34%, when compared to last year.